ARK Investment Management »

Crispr Therapeutics shares owned by ARK Investment Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by ARK Investment Management from 13F filings

Historical chart of ARK Investment Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by ARK Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by ARK Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $534M 8.5M 62.60
2023-09-30 $325M 7.2M 45.39
2023-06-30 $412M 7.3M 56.14
2023-03-31 $361M 8.0M 45.23
2022-12-31 $318M 7.8M 40.65
2022-09-30 $538M 8.2M 65.35
2022-06-30 $565M 9.7M 58.05
2022-03-31 $590M 9.4M 62.77
2021-12-31 $689M 9.1M 75.78
2021-09-30 $849M 7.6M 111.93
2021-06-30 $1.3B 7.8M 161.89
2021-03-31 $1.0B 8.3M 121.85
2020-12-31 $1.6B 10M 153.11
2020-09-30 $707M 8.5M 83.64
2020-06-30 $477M 6.5M 73.49
2020-03-31 $182M 4.3M 42.41
2019-12-31 $180M 3.0M 60.91
2019-09-30 $114M 2.8M 40.99
2019-06-30 $128M 2.7M 47.10
2019-03-31 $72M 2.0M 35.72
2018-12-31 $38M 1.3M 28.57
2018-09-30 $65M 1.5M 44.35
2018-06-30 $27M 467k 58.76
2018-03-31 $3.3M 73k 45.72
2017-12-31 $737k 31k 23.48
2017-06-30 $206k 13k 15.98